Licensee Application Sample Clauses

Licensee Application. 4.6.1. This License is expressly made contingent upon Licensee obtaining all certificates, permits, entitlements, environmental review, studies, and other approvals that any federal, state, or local authority may require for the construction and operation of Licensee’s Facilities, the Integrated Facilities, and Accessory Structures, if applicable. Licensee shall bear the sole cost and expense related to the procurement of these approvals. If Licensee fails to procure all required governmental approvals within a reasonable period of time, not to exceed one year from the Effective Date, Licensor shall have the right to terminate the Agreement with five (5) Days written notice.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Licensee Application. Licensee’s right to use the Premises is expressly 10 made contingent upon its obtaining all the certificates, permits, zoning, land use entitlements, 11 including environmental review and approvals, interference study, engineering study and other 12 approvals that may be required by any federal, state, or local authority for Licensee, or its 13 assigns, and operating in conformance with such land use approvals and entitlements to 14 construct and operate mobile/wireless telecommunications facilities on the Premises. If the 15 Licensee does not meet the requirements referenced in this Section 3.1 within a reasonable 16 period of time, not to exceed one year from the Effective Date, this License shall terminate.
Sample 1
Licensee Application. 2.5.1.The Licensee Application may only use the Specification and incorporate the Runtime Component in the manner prescribed by Entrust in the API documentation, for the Permitted Use.
Sample 1
Licensee Application. Licensee shall indicate its interest in licensing the Facilities, changing frequency or power levels or modifying Equipment at any Site by submitting a Site Engineering Application to Licensor, together with a non-refundable Site Application Fee of $1,500.00. The Site Application Fee shall be applied to reduce the cost of other Licensor provided services at the same Site, however, the Site Application Fee may not be applied to the Site Audit Fee, if applicable. An additional Site Engineering Application shall be submitted for any change to the Equipment originally authorized by the SLA or a previously approved Site Engineering Application if such change results in increased tower loading, occupation of additional ground space or operation of Equipment on frequencies or at power levels not previously approved, however, no additional Site Application Fee shall be due with the new Site Engineering Application if the change does not increase tower loading or occupation of ground space. Licensee's approved Site Engineering Application shall be an exhibit to the SLA and shall define Licensee's authorized use of the Facilities. Upon Licensor's approval of Licensee's Site Engineering Application which approval shall not be unreasonably withheld, Licensor and Licensee shall execute a SLA, which shall become effective and become part of this Agreement on the SLA Commencement Date.
Sample 1
Licensee Application. Section 2.1 "Licensee Application" of the MLA is deleted in its entirety. A new Section 2.1 "Site Engineering Application" is hereby added to the MLA to read as follows:
Sample 1
Licensee Application. Licensee Chips are being designed for the following applications: networking chips.
Sample 1
Licensee Application. Licensee Chips may be designed for the following applications: all applications. The reference to “the applicable Licensee Application” in Section 1.4 of the Master Agreement is not intended as, and shall not be interpreted to be, any limitation on the applications for which any Licensee Chips may be designed under this Technology Schedule.
Sample 1
AutoNDA by SimpleDocs

Related to Licensee Application

  • Regulatory Applications (a) Sky and SBI and their respective Subsidiaries shall cooperate and use their respective reasonable best efforts to prepare, within 45 days of the execution of this Agreement, all documentation and requests for regulatory approval, to timely effect all filings and to obtain all permits, consents, approvals and authorizations of all third parties and Governmental Authorities and Regulatory Authorities necessary to consummate the transactions contemplated by this Agreement. Each of Sky and SBI shall have the right to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating to the exchange of information, with respect to, and shall be provided in advance so as to reasonably exercise its right to review in advance, all material written information submitted to any third party or any Governmental Authority or Regulatory Authority in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto agrees to act reasonably and as promptly as practicable. Each party hereto agrees that it will consult with the other party hereto with respect to the obtaining of all material permits, consents, approvals and authorizations of all third parties and Governmental Authorities or Regulatory Authorities necessary or advisable to consummate the transactions contemplated by this Agreement and each party will keep the other party apprised of the status of material matters relating to completion of the transactions contemplated hereby.

  • Patent Applications It is understood by the parties that, pursuant to the Baylor Technology Transfer Agreement, MAS has the initial responsibility for filing, prosecution and maintenance of Patents and Patent Applications covering the Baylor Technology. The parties agree that, as between MAS and CTI, MAS shall be responsible for deciding whether and how to file, prosecute and maintain the Patents and Patent Applications, provided that:

  • License; Use Upon delivery to an Authorized Person or a person reasonably believed by Custodian to be an Authorized Person of the Fund of software enabling the Fund to obtain access to the System (the “Software”), Custodian grants to the Fund a personal, nontransferable and nonexclusive license to use the Software solely for the purpose of transmitting Written Instructions, receiving reports, making inquiries or otherwise communicating with Custodian in connection with the Account(s). The Fund shall use the Software solely for its own internal and proper business purposes and not in the operation of a service bureau. Except as set forth herein, no license or right of any kind is granted to the Fund with respect to the Software. The Fund acknowledges that Custodian and its suppliers retain and have title and exclusive proprietary rights to the Software, including any trade secrets or other ideas, concepts, know-how, methodologies, or information incorporated therein and the exclusive rights to any copyrights, trademarks and patents (including registrations and applications for registration of either), or other statutory or legal protections available in respect thereof. The Fund further acknowledges that all or a part of the Software may be copyrighted or trademarked (or a registration or claim made therefor) by Custodian or its suppliers. The Fund shall not take any action with respect tot the Software inconsistent with the foregoing acknowledgement, nor shall the Fund attempt to decompile, reverse engineer or modify the Software. The Fund may not xxx, sell, lease or provide, directly or indirectly, any of the Software of any portion thereof to any other person or entity without Custodian’s prior written consent. The Fund may not remove any statutory copyright notice or other notice included in the Software or on any media containing the Software. The Fund shall reproduce any such notice on any reproduction of the Software and shall add any statutory copyright notice or other notice to the Software or media upon Custodian’s request.

  • General Application The rules set forth below in this Article IV shall apply for the purposes of determining each Member’s general allocable share of the items of income, gain, loss or expense of the Company comprising Net Income or Net Loss of the Company for each Fiscal Year, determining special allocations of other items of income, gain, loss and expense, and adjusting the balance of each Member’s Capital Account to reflect the aforementioned general and special allocations. For each Fiscal Year, the special allocations in Section 4.4 shall be made immediately prior to the general allocations of Section 4.3.

  • Notice, Application The Agent shall have received (with, in the case of the initial Revolving Loan only, a copy for each Bank) a Notice of Borrowing or a Notice of Conversion/Continuation, as applicable or in the case of any Issuance of any Letter of Credit, the Issuing Bank and the Agent shall have received an L/C Application or L/C Amendment Application, as required under Section 3.2;

  • Listing Application If shares of any class of stock of the Company shall be listed on a national securities exchange, the Company shall, at its expense, include in its listing application all of the shares of the listed class then owned by any Investor.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensee Licensee represents and warrants that:

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!